European Union Regulator Says Benefits Outweigh Risks Of Johnson & Johnson Vaccine

The European Medicines Agency says there is a possible link between the J&J vaccine and rare blood clotting. It says a warning should be added to the label, but says benefits outweigh the risks.

[Copyright 2021 NPR]